document optical character recognition (ocr)-implementing device Search Results


abbyy® finereader tools  (ABBYY USA Software House Inc)
90
ABBYY USA Software House Inc abbyy® finereader tools
Abbyy® Finereader Tools, supplied by ABBYY USA Software House Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/abbyy++finereader+tools/us11120062-116-12-15
Average 90 stars, based on 1 article reviews
abbyy® finereader tools - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
abbyy finereader ocr  (ABBYY USA Software House Inc)
90
ABBYY USA Software House Inc abbyy finereader ocr
Abbyy Finereader Ocr, supplied by ABBYY USA Software House Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/ocr+software+abbyy+finereader/us08254681-43-13-12
Average 90 stars, based on 1 article reviews
abbyy finereader ocr - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
scansoft ocr software  (Scansoft Inc)
90
Scansoft Inc scansoft ocr software
Scansoft Ocr Software, supplied by Scansoft Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/omnipage+pro/us07366339-178-9-13
Average 90 stars, based on 1 article reviews
scansoft ocr software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
extracellular ocr plate assay kit  (Dojindo Labs)
95
Dojindo Labs extracellular ocr plate assay kit
Extracellular Ocr Plate Assay Kit, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/Extracellular+OCR+Plate+Assay+Kit/custom%40e297%4040045380
Average 95 stars, based on 1 article reviews
extracellular ocr plate assay kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
leadtools ocr  (LEAD Technologies)
90
LEAD Technologies leadtools ocr
This figure shows the graphical user interface and modular workflow of three main components: Text, Image and <t>OCR.</t> <t>A</t> <t>PDF</t> document is input and processed by MSL. Text module provides extracted, searched and marginalized text in reading order, and file attributes. Image component provides the preview of extracted images from the document. OCR component provides extracted text from selected and processed image.
Leadtools Ocr, supplied by LEAD Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/leadtools+ocr/pmc05897790-142-53-53
Average 90 stars, based on 1 article reviews
leadtools ocr - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ocr-507  (Satlantic Inc)
90
Satlantic Inc ocr-507
This figure shows the graphical user interface and modular workflow of three main components: Text, Image and <t>OCR.</t> <t>A</t> <t>PDF</t> document is input and processed by MSL. Text module provides extracted, searched and marginalized text in reading order, and file attributes. Image component provides the preview of extracted images from the document. OCR component provides extracted text from selected and processed image.
Ocr 507, supplied by Satlantic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/ocr+507/10__5194_slash_essd___16___5477___2024-45-22-14
Average 90 stars, based on 1 article reviews
ocr-507 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ocrelizumab  (NeuroTransData GmbH)
90
NeuroTransData GmbH ocrelizumab
Love plots for absolute standardized differences after PSM for matching factors defined for relapse and 24W-CDP outcomes. 24W-CDP, 24-week confirmed disability progression; DMF, dimethyl fumarate; EDSS, Expanded Disability Status Scale; FTY, fingolimod; GA, glatiramer acetate; Gd+, gadolinium-enhancing; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; <t>OCR,</t> <t>ocrelizumab;</t> PSM, propensity score-matched; TERI, teriflunomide.
Ocrelizumab, supplied by NeuroTransData GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/dmf/pmc11406495-157-23-19
Average 90 stars, based on 1 article reviews
ocrelizumab - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ocr  (Kaggle Inc)
86
Kaggle Inc ocr
Love plots for absolute standardized differences after PSM for matching factors defined for relapse and 24W-CDP outcomes. 24W-CDP, 24-week confirmed disability progression; DMF, dimethyl fumarate; EDSS, Expanded Disability Status Scale; FTY, fingolimod; GA, glatiramer acetate; Gd+, gadolinium-enhancing; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; <t>OCR,</t> <t>ocrelizumab;</t> PSM, propensity score-matched; TERI, teriflunomide.
Ocr, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/ocr/10__3390_slash_math13193093-125-19-22
Average 86 stars, based on 1 article reviews
ocr - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
satlantic ocr-3000  (Satlantic Inc)
90
Satlantic Inc satlantic ocr-3000
Love plots for absolute standardized differences after PSM for matching factors defined for relapse and 24W-CDP outcomes. 24W-CDP, 24-week confirmed disability progression; DMF, dimethyl fumarate; EDSS, Expanded Disability Status Scale; FTY, fingolimod; GA, glatiramer acetate; Gd+, gadolinium-enhancing; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; <t>OCR,</t> <t>ocrelizumab;</t> PSM, propensity score-matched; TERI, teriflunomide.
Satlantic Ocr 3000, supplied by Satlantic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/ocr+200/10__3390_slash_rs12081322-311-37-36
Average 90 stars, based on 1 article reviews
satlantic ocr-3000 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ocr drug  (HealthCore Inc)
90
HealthCore Inc ocr drug
Love plots for absolute standardized differences after PSM for matching factors defined for relapse and 24W-CDP outcomes. 24W-CDP, 24-week confirmed disability progression; DMF, dimethyl fumarate; EDSS, Expanded Disability Status Scale; FTY, fingolimod; GA, glatiramer acetate; Gd+, gadolinium-enhancing; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; <t>OCR,</t> <t>ocrelizumab;</t> PSM, propensity score-matched; TERI, teriflunomide.
Ocr Drug, supplied by HealthCore Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/ocr+drug/pm36970763-1-17-5
Average 90 stars, based on 1 article reviews
ocr drug - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ocr products and systems  (Scansoft Inc)
90
Scansoft Inc ocr products and systems
Love plots for absolute standardized differences after PSM for matching factors defined for relapse and 24W-CDP outcomes. 24W-CDP, 24-week confirmed disability progression; DMF, dimethyl fumarate; EDSS, Expanded Disability Status Scale; FTY, fingolimod; GA, glatiramer acetate; Gd+, gadolinium-enhancing; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; <t>OCR,</t> <t>ocrelizumab;</t> PSM, propensity score-matched; TERI, teriflunomide.
Ocr Products And Systems, supplied by Scansoft Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/ocr+package/us08864029-217-3-12
Average 90 stars, based on 1 article reviews
ocr products and systems - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ocr-504 downward irradiance and upward radiance sensors  (Satlantic Inc)
90
Satlantic Inc ocr-504 downward irradiance and upward radiance sensors
Love plots for absolute standardized differences after PSM for matching factors defined for relapse and 24W-CDP outcomes. 24W-CDP, 24-week confirmed disability progression; DMF, dimethyl fumarate; EDSS, Expanded Disability Status Scale; FTY, fingolimod; GA, glatiramer acetate; Gd+, gadolinium-enhancing; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; <t>OCR,</t> <t>ocrelizumab;</t> PSM, propensity score-matched; TERI, teriflunomide.
Ocr 504 Downward Irradiance And Upward Radiance Sensors, supplied by Satlantic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/document+optical+character+recognition+(ocr)-implementing+device/micropro+free+fall+profiler/10__1029_slash_2007gl029823-29-45-39
Average 90 stars, based on 1 article reviews
ocr-504 downward irradiance and upward radiance sensors - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


This figure shows the graphical user interface and modular workflow of three main components: Text, Image and OCR. A PDF document is input and processed by MSL. Text module provides extracted, searched and marginalized text in reading order, and file attributes. Image component provides the preview of extracted images from the document. OCR component provides extracted text from selected and processed image.

Journal: F1000Research

Article Title: MSL: Facilitating automatic and physical analysis of published scientific literature in PDF format

doi: 10.12688/f1000research.7329.3

Figure Lengend Snippet: This figure shows the graphical user interface and modular workflow of three main components: Text, Image and OCR. A PDF document is input and processed by MSL. Text module provides extracted, searched and marginalized text in reading order, and file attributes. Image component provides the preview of extracted images from the document. OCR component provides extracted text from selected and processed image.

Article Snippet: The work-flow of MSL is divided into two processes: (I) extraction and marginalization of text with respect to the division and placement of text in PDF file and keyword based search by using the iTextSharp, Bytescoute, Spire PDF libraries, and (II) extraction and analysis of figures by using the Spire PDF library and LEADTOOLS OCR.

Techniques:

This figure shows the conceptual architecture of the MSL application, which consists of three main components: Text, Image and OCR, and nine sub-components: Text File, Image File, Visualize Image, PDF File, LEADTOOLS, XML File, iTEXTSharp, Bytescout, Spire. As figure shows, Text component applies iTEXTSharp, Bytescout, Spire to extract the text from PDF document and write output in XML file. Image components applies Spire to extract images from the PDF document and visualize that using Visualize Image. OCR component applied LEADTOOLS to extract text from images and export that to PDF format.

Journal: F1000Research

Article Title: MSL: Facilitating automatic and physical analysis of published scientific literature in PDF format

doi: 10.12688/f1000research.7329.3

Figure Lengend Snippet: This figure shows the conceptual architecture of the MSL application, which consists of three main components: Text, Image and OCR, and nine sub-components: Text File, Image File, Visualize Image, PDF File, LEADTOOLS, XML File, iTEXTSharp, Bytescout, Spire. As figure shows, Text component applies iTEXTSharp, Bytescout, Spire to extract the text from PDF document and write output in XML file. Image components applies Spire to extract images from the PDF document and visualize that using Visualize Image. OCR component applied LEADTOOLS to extract text from images and export that to PDF format.

Article Snippet: The work-flow of MSL is divided into two processes: (I) extraction and marginalization of text with respect to the division and placement of text in PDF file and keyword based search by using the iTextSharp, Bytescoute, Spire PDF libraries, and (II) extraction and analysis of figures by using the Spire PDF library and LEADTOOLS OCR.

Techniques:

This figure shows document image analysis, text extraction and PDF conversion. A figure (based on three panels; including two charts, one image and a table) is selected from one of the randomly selected papers 2 6 . OCR (LEADTOOLS) is applied to extract and report the text from the figure in simple text form (section: Extracted Text from Figure) and in PDF file with similar margins to the original figure (section: Exported text in PDF format).

Journal: F1000Research

Article Title: MSL: Facilitating automatic and physical analysis of published scientific literature in PDF format

doi: 10.12688/f1000research.7329.3

Figure Lengend Snippet: This figure shows document image analysis, text extraction and PDF conversion. A figure (based on three panels; including two charts, one image and a table) is selected from one of the randomly selected papers 2 6 . OCR (LEADTOOLS) is applied to extract and report the text from the figure in simple text form (section: Extracted Text from Figure) and in PDF file with similar margins to the original figure (section: Exported text in PDF format).

Article Snippet: The work-flow of MSL is divided into two processes: (I) extraction and marginalization of text with respect to the division and placement of text in PDF file and keyword based search by using the iTextSharp, Bytescoute, Spire PDF libraries, and (II) extraction and analysis of figures by using the Spire PDF library and LEADTOOLS OCR.

Techniques: Extraction

This figure shows document image analysis, text extraction and PDF conversion. First, scanned image based page of one of the randomly selected papers is processed using OCR (LEADTOOLS). Text is extracted from the image and a new PDF is generated, which is based on the text, placed with similar margins to the image file.

Journal: F1000Research

Article Title: MSL: Facilitating automatic and physical analysis of published scientific literature in PDF format

doi: 10.12688/f1000research.7329.3

Figure Lengend Snippet: This figure shows document image analysis, text extraction and PDF conversion. First, scanned image based page of one of the randomly selected papers is processed using OCR (LEADTOOLS). Text is extracted from the image and a new PDF is generated, which is based on the text, placed with similar margins to the image file.

Article Snippet: The work-flow of MSL is divided into two processes: (I) extraction and marginalization of text with respect to the division and placement of text in PDF file and keyword based search by using the iTextSharp, Bytescoute, Spire PDF libraries, and (II) extraction and analysis of figures by using the Spire PDF library and LEADTOOLS OCR.

Techniques: Extraction, Generated

Comparative analysis of MSL with different, earlier discussed related applications. This table compare different related applications (A-PDF, PDF Merge Split Extract, BePDF, KPDF, MuPDF, Xpdf tool, Power PDF, PDF2HTML, PDF-Analyzer, XED, Dolores, Layout-aware) to MSL. Comparison is drawn based on some major elements (Open source, PDF text extraction, PDF image extraction, OCR, Searching, IMRAD, Customizable and FREE).

Journal: F1000Research

Article Title: MSL: Facilitating automatic and physical analysis of published scientific literature in PDF format

doi: 10.12688/f1000research.7329.3

Figure Lengend Snippet: Comparative analysis of MSL with different, earlier discussed related applications. This table compare different related applications (A-PDF, PDF Merge Split Extract, BePDF, KPDF, MuPDF, Xpdf tool, Power PDF, PDF2HTML, PDF-Analyzer, XED, Dolores, Layout-aware) to MSL. Comparison is drawn based on some major elements (Open source, PDF text extraction, PDF image extraction, OCR, Searching, IMRAD, Customizable and FREE).

Article Snippet: The work-flow of MSL is divided into two processes: (I) extraction and marginalization of text with respect to the division and placement of text in PDF file and keyword based search by using the iTextSharp, Bytescoute, Spire PDF libraries, and (II) extraction and analysis of figures by using the Spire PDF library and LEADTOOLS OCR.

Techniques: Comparison, Extraction

Love plots for absolute standardized differences after PSM for matching factors defined for relapse and 24W-CDP outcomes. 24W-CDP, 24-week confirmed disability progression; DMF, dimethyl fumarate; EDSS, Expanded Disability Status Scale; FTY, fingolimod; GA, glatiramer acetate; Gd+, gadolinium-enhancing; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; PSM, propensity score-matched; TERI, teriflunomide.

Journal: Journal of Central Nervous System Disease

Article Title: Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments

doi: 10.1177/11795735241260563

Figure Lengend Snippet: Love plots for absolute standardized differences after PSM for matching factors defined for relapse and 24W-CDP outcomes. 24W-CDP, 24-week confirmed disability progression; DMF, dimethyl fumarate; EDSS, Expanded Disability Status Scale; FTY, fingolimod; GA, glatiramer acetate; Gd+, gadolinium-enhancing; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; PSM, propensity score-matched; TERI, teriflunomide.

Article Snippet: CI, confidence interval; DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; HR, hazard ratio; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; TERI, teriflunomide.

Techniques:

Baseline demographics and clinical characteristics of matched study cohorts.

Journal: Journal of Central Nervous System Disease

Article Title: Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments

doi: 10.1177/11795735241260563

Figure Lengend Snippet: Baseline demographics and clinical characteristics of matched study cohorts.

Article Snippet: CI, confidence interval; DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; HR, hazard ratio; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; TERI, teriflunomide.

Techniques:

Effectiveness of OCR in OPERA studies compared with index therapies in NTD-matched cohorts over 288 weeks.

Journal: Journal of Central Nervous System Disease

Article Title: Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments

doi: 10.1177/11795735241260563

Figure Lengend Snippet: Effectiveness of OCR in OPERA studies compared with index therapies in NTD-matched cohorts over 288 weeks.

Article Snippet: CI, confidence interval; DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; HR, hazard ratio; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; TERI, teriflunomide.

Techniques: Significance Assay

Time to first relapse in patients receiving OCR in OPERA vs patients receiving each index therapy in the NTD-matched cohorts over 288 weeks. CI, confidence interval; DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; HR, hazard ratio; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; TERI, teriflunomide.

Journal: Journal of Central Nervous System Disease

Article Title: Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments

doi: 10.1177/11795735241260563

Figure Lengend Snippet: Time to first relapse in patients receiving OCR in OPERA vs patients receiving each index therapy in the NTD-matched cohorts over 288 weeks. CI, confidence interval; DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; HR, hazard ratio; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; TERI, teriflunomide.

Article Snippet: CI, confidence interval; DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; HR, hazard ratio; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; TERI, teriflunomide.

Techniques:

Time to 24W-CDP relapse in patients receiving OCR in OPERA vs patients receiving each index therapy in the NTD-matched cohorts over 288 weeks. 24W-CDP, 24-week confirmed disability progression; CI, confidence interval; DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; HR, hazard ratio; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; TERI, teriflunomide.

Journal: Journal of Central Nervous System Disease

Article Title: Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments

doi: 10.1177/11795735241260563

Figure Lengend Snippet: Time to 24W-CDP relapse in patients receiving OCR in OPERA vs patients receiving each index therapy in the NTD-matched cohorts over 288 weeks. 24W-CDP, 24-week confirmed disability progression; CI, confidence interval; DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; HR, hazard ratio; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; TERI, teriflunomide.

Article Snippet: CI, confidence interval; DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; HR, hazard ratio; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; OCR, ocrelizumab; TERI, teriflunomide.

Techniques: